Birgatinib is a medication used to treat a certain type of blood cancer called chronic myeloid leukemia (CML). It works by blocking the activity of certain proteins that help cancer cells grow and divide.

Birgatinib is usually taken by mouth once daily, with or without food. The recommended dose is usually 180 mg per day.

Like all medications, birgatinib can cause some side effects. Common side effects may include fatigue, nausea, diarrhea, headache, and decreased appetite. Talk to your healthcare provider if you experience any side effects or have any concerns about taking this medication.